Navigation Links
Clinilabs Launches Research Volunteer Authentication Initiative
Date:4/3/2013

NEW YORK, April 3, 2013 /PRNewswire-iReach/ -- Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, today announced that it has launched a subject authentication initiative at its Phase 1 sites in New York and New Jersey.  This initiative includes the authentication of subject identity and medical history, background checks, and tracking of prior study participation in order to eliminate ineligible subjects from clinical trials.  The Company has selected Verified Clinical Trials (VCT) to assist with this initiative, implementing the VCT database registry system.  VCT's registry is designed to stop the professional research subject from enrolling in multiple clinical trials simultaneously – a situation known as dual enrollment.  This collaboration between Clinilabs and VCT is a reflection of both companies' commitment to volunteer safety and data quality.

Failure to document the identity of study volunteers, inaccuracies in subjects' medical histories, and multiple concurrent enrollments have become a serious problem in the clinical research world.  Study volunteers interested in free care or compensation may present inaccurate information in order to gain entry to clinical trials, and some may jump from one study to another without waiting for enough time to lapse between treatments.  This type of research volunteer places everyone at risk including the drug manufacturer, the research site, and most importantly, themselves, potentially jeopardizing their health. Furthermore, this may compromise data quality.

Clinilabs and Verified Clinical Trials are determined to meet the challenge of subject enrollment in a proactive way, ensuring that only eligible subjects are enrolled in clinical trials. Dr. Gary Zammit , President and CEO states, "Most of us in the industry recognize the existence and the significant ramifications of improper enrollment in clinical trials, but we have never before been able to quantify it, detect it, or stop it.  Clinilabs has taken the lead among CROs to provide its clients with a thoughtfully-conceived approach to subject authentication – ensuring the accuracy and integrity of volunteer data."

Dr. Mitchell Efros , CEO of Verified Clinical Trials states, "Clinilabs has joined an impressive cohort of companies on a local and national level to improve the quality of their trials. The recognition of dual enrollment in clinical research and use of the VCT system has literally exploded as of late".  Dr. Efros adds, "We are very excited to have a company like Clinilabs join our expansive network that includes and focuses on both early and late phase trials. Clinilabs has joined the largest clinical research database network across North America and only strengthens this cooperative registry."

About Clinilabs Inc.

Clinilabs is a full-service contract research organization (CRO) that specializes in early-phase studies, from first-in-human to proof-of-concept, with normal healthy volunteers and patient populations.  The company owns and operates two Phase I units in the US, and maintains a network of highly qualified investigator sites for multicenter Phase II studies Worldwide.  Specialty projects, including pharmacodynamic, biomarker, cardiac safety, sleep/wakefulness, metabolic, and Japanese bridging are among our strengths.  Clinilabs is recognized globally as a leading specialty CRO, offering an alternative to large CRO for specialty projects.  For more information, please visit www.clinilabs.com.

About Verified Clinical Trials

Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value added services to the clinical research site, CRO, and Pharmaceutical Sponsor, that prove invaluable with regards to financial and legal issues and liabilities.  For more information, visit http://www.verifiedclinicaltrials.com.

Clinilabs Contact:
Hannah D'Aoust
Phone:  (646) 215-6480
hdaoust@clinilabs.com.

Verified Clinical Trials Contact:
Kerri Weingard ANP
Chief Operating Officer
Phone: (516) 998-7499
kweingard@verifiedclinicaltrials.com



Media Contact:

Hannah DAoust Clinilabs, 646-215-6480, hdaoust@clinilabs.com



News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Clinilabs
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinilabs Opens Phase I Unit In Eatontown, New Jersey
2. Thoma & Sutton Eye Care Launches ChromaGen Life-Changing Lens Technology
3. SonaCare Medical Successfully Launches New Products at European Association of Urology (EAU)
4. Omegafort SCC Launches Worlds Highest-Potency Omega-3 Supplement for Professional Athletes
5. BioSpace Launches Bio NC Hotbed Campaign, New Map Design
6. Trovagene Launches Urine-Based HPV Test
7. H.I.M. ON CALL Launches Dual Coding Service to Help Hospitals Prepare for ICD-10
8. MAQUET Medical Systems USA Launches The MIRA-i CS Retractor System For Use During Minimally Invasive Revascularization Procedures
9. Medical Supply Company Joy Comfort LLC Launches New E-Commerce Website
10. CVS/pharmacy Launches Innovative New iPad App Featuring a 3D Virtual Store and Digital Pharmacy Experience
11. Fluke Biomedical launches six translated websites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... India , February 22, 2017 ... Radio Synthesis Modules Market: Global Opportunity Analysis and Industry Forecast, ... worth $20 million in 2015 and projected to reach $32 ... 2016 to 2022. North America accounted ... and unit volumes, whereas Asia-Pacific region ...
(Date:2/22/2017)... A research report by Arcview Market Research focused on cannabis ... changing landscape of the legal market reveals that regulated cannabis sales ... , a 30% increase from 2015. According to the research ... 2021 representing a 26 percent compound annual growth rate. The use ... Canada is gradually becoming more mainstream thanks ...
(Date:2/22/2017)... Feb 22, 2017 Research and Markets has ... & Trends - Industry Forecast to 2025" report to their offering. ... The Global Clot Management ... over the next decade to reach approximately $2.1 billion by 2025. ... for all the given segments on global as well as regional levels ...
Breaking Medicine Technology:
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... launch of ProGen™ PRP, the latest innovation in the delivery of Platelet Rich ... care, aesthetics, cardiovascular and pain management, to accelerate tissue synthesis and provide a ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent of American ... that family members or friends have also commented about their poor hearing. However, ... hearing aids. One reason, suggested by 89 percent of American respondents, is that ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pet obesity in the U.S. ... dogs, according to the Association for Pet Obesity Prevention (APOP). During the ninth annual ... issues such as the benefits of corn and grains, value of raw and organic ...
(Date:2/22/2017)... ... 22, 2017 , ... BrightStar Care Charleston , a home care and ... South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, March 23, 2017, ... a tremendous resource in our community. We are thrilled to participate in this event ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... - the Vector™ Series Multi-Cook Oven offers up to four ovens in one. ... Structured Air Technology™ for unmatched evenness in cooking. Alto-Shaam has partnered with Appliance ...
Breaking Medicine News(10 mins):